2025 Fellowship Recipients


SITC-Genmab Cancer Immunotherapy in Hematologic Malignancies: DLBCL, FL, and CLL Translational Fellowship

Mohamad Ali T. Najia, PhD

Mohamad Ali Najia, PhD
Boston Children's Hospital


Award Amount

 $100,000 (one year)


Project Title

“Epigenetic reactivation of endogenous retroelements to stimulate anti-tumor immunity in DLBCL”



SITC-Merck Cancer Immunotherapy Clinical Fellowship

Anna Ralser, MD, PhD

Anna Ralser, MD, PhD
The J. David Gladstone Institutes


Award Amount

 $100,000 (one year)


Project Title

“Inducing immune niches to unlock anti-tumor responses in immunotherapy-resistant CRC”


Merck


SITC Cancer Immunotherapy Fellowship

Ivan Susin Pires, PhD

Ivan Susin Pires, PhD
Brigham and Women's Hospital


Award Amount

 $100,000 (one year)


Project Title

“Engineering Multivalent Nanobody Constructs for Enhanced Cancer Immunotherapy”


SITC

This year’s SITC Forward Fund Fellowships were made possible through the generosity of Genmab, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. and the Society for Immunotherapy of Cancer.

View Past SITC Fellowship Recipients

20242023 2022 2021 2020 2019 2018 2017 2016 2015 2014